person

Jacob O.

Country
Denmark
Department
Pediatric Surgery

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 7 partner sites.

Specializations

Pediatric Gastroenterology

The investigator specializes in treating children with esophageal atresia and its associated complications, particularly focusing on innovative therapeutic approaches for post-surgical complications.

  • Esophageal stricture management
  • Post-surgical care in pediatric patients
  • Minimally invasive therapeutic techniques

Their research interests center on developing preventive treatment strategies for refractory strictures in pediatric patients who have undergone esophageal repair procedures.

Interventional Therapeutics

The investigator explores advanced treatment modalities including intralesional steroid injections for managing pediatric esophageal conditions. Their work focuses on optimizing therapeutic interventions to reduce the need for repeated procedures.

  • Therapeutic injection techniques
  • Stricture prevention strategies
  • Pediatric endoscopic procedures

Their expertise extends to developing protocols for early intervention in post-surgical complications of esophageal repair.

Pediatric Surgery Outcomes

The investigator's work encompasses improving outcomes following esophageal atresia repair, with particular attention to reducing post-operative complications and enhancing recovery protocols.

  • Post-operative care optimization
  • Complication prevention
  • Long-term outcome assessment

Their research aims to establish effective treatment protocols that minimize the need for repeated surgical interventions in pediatric patients.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.